In this review, we will summarise the current evidence on (a) the intracellular distribution and trafficking of APP, (b) the intracellular processing locations of APP and (c) the effect of selected familial AD mutations on APP intracellular trafficking and processing and the production of Aβ, taking the above challenges into account. The gene discussed is APP; the disease is Alzheimer disease.